Buprenorphine ER versus Ethiqa XR
As a reminder, rodent users currently have two options when providing long-lasting or extended-release opioid pain relief in rodents - either Ethiqa XR or Buprenorphine ER. Below is a comparison of the two drugs:
|
|
Ethiqa XR |
Buprenorphine ER |
|---|---|---|
|
FDA Approval Status |
FDA-Approved |
Compounded |
|
Analgesia Length |
Up to 72 hrs |
Up to 72 hrs |
|
Dosage |
Mouse: 3.25 mg/kg SQ Rat: 0.65 mg/kg SQ |
Mouse: 1-1.2 mg/kg SQ Rat: 1-1.2 mg/kg SQ |
|
Concentration of vial |
1.3 mg/mL |
0.5, 1, and 3 mg/mL |
|
Volume of vial |
3 mL |
5 mL |
|
Shelf Life Unopened |
24 months |
Typically, 12 months from date of purchase |
|
Shelf Life after Piercing Rubber Seal |
90 days |
30 days |
|
Cost per vial (subject to change) |
$415 |
$150-190 |
The compounded Buprenorphine ER medication requires a prescription to be called into Wedgewood pharmacy by Dr. Bradley. To aid in this process, please provide the following information to Dr. Bradley.
- Lab DEA License Holder name and address
- Number of vials (they are 5mL in size)
- Species
- Number of animals that will receive the medication
- Average weight of the animals
- Average age of the population
Contact info
Julie O'Connor
Director, Research Communications
Phone: 313-577-8845
Email: julie.oconnor@wayne.edu